AIDS activists urge Gilead to lower $1.8K pricetag of new HIV-prevention drug
AIDS
Healthcare Foundation argued that since Gilead has already made billions in
profit from Truvada and its other HIV/AIDS drugs, it should lower ...
|
View article...